Suppression of VEGF and inflammatory cytokines, modulation of Annexin A1 and organ functions by galloylquinic acids in breast cancer model

The ongoing development of novel drugs for breast cancer aims to improve therapeutic outcomes, reduce toxicities, and mitigate resistance to chemotherapeutic agents. Doxorubicin (Dox) is known for its significant side effects caused by non-specific cytotoxicity. In this study, we investigated the an...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd El-Salam, Mohamed, El-Tanbouly, Ghada, Bastos, Jairo, Metwaly, Heba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382581/
https://www.ncbi.nlm.nih.gov/pubmed/37507468
http://dx.doi.org/10.1038/s41598-023-37654-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382581/
https://www.ncbi.nlm.nih.gov/pubmed/37507468
http://dx.doi.org/10.1038/s41598-023-37654-4

Ejemplares similares